NCT05570929
LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration
StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Jun 2024); last known: Recruiting
- Notable Primary completion date: Nov 1, 2024 to Nov 1, 2025
- Study completion date: Nov 1, 2025 to Nov 1, 2026
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Nov 1, 2022 to Feb 7, 2023
- Secondary endpoints: details revised at 10 of 10 entries
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Fecal microbiome taxonomy (Shannon-Index)
Timeframe: Change from Baseline at 24 weeks
Secondary (10)
Functional capacity of gut microbiota
Frequency of circulating T-cell subtypes
Serum tryptophan metabolites concentration
Serum short-chain fatty acid concentration
Fecal tryptophan metabolites concentration
Show 5 moreShow less
Fecal short-chain fatty acid concentration
Office systolic blood pressure
Office diastolic blood pressure
Body fat content
Fat free mass
Arms and interventions
Kidney Donor
Defined as a human individual donating a kidney
Kidney Recipient
Defined as a patient suffering from chronic kidney disease being the recipient of a kidney transplant
Sites
1 site in 1 country
- Experimental and Clinical Research CenterBerlin, Germany